Supervivencia a mediano plazo y estado funcional de pacientes con estenosis valvular aórtica grave sometidos a implante de válvula aórtica transcatéter

4_alfonsina_candiello_articulo
Alfonsina Candiello, Fernando Cura, Mariano Albertal, Lucio T. Padilla, Gerardo Nau, Florencia Castro, Ricardo Ronderos, Gustavo Avegliano, Daniel Navia, Jorge Belardi

More articles by this author

Denervación Simpática Renal Percutánea

Fernando Luiz de Melo Bernardi, Wilton Francisco Gomes, André Gasparini Spadaro, Antônio Esteves Filho, Luiz Aparecido Bortolotto, Maurício Ibrahim Scanavacca, Pedro Alves Lemos

Tratamiento de perforación coronaria Tipo III con la técnica de doble catéter-guía

Evandro Martins-Filho, Tarcísio Campostrini Borghi Jr., Marcelo Aguilar Puzzi, Ricardo Costa, Dimytri Siqueira, Rodolfo Staico, Alexandre Abizaid

Intervención coronaria percutánea por las vías radial y femoral: comparación entre las molestias relacionadas al procedimiento y costos

Maria Helena Almeida, George C. X. Meireles, Edna V. Siva, J. Ribamar Costa Jr., Rodolfo Staico, Dimytri Alexandre Siqueira, Ricardo Costa, Alexandre Abizaid

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...